189 related articles for article (PubMed ID: 7525344)
1. Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein.
Tedeschi A; Milazzo N; Miadonna A
Eur Respir J; 1994 Aug; 7(8):1445-51. PubMed ID: 7525344
[TBL] [Abstract][Full Text] [Related]
2. Nasal neutrophilia and release of myeloperoxidase induced by nasal challenge with platelet activating factor: different degrees of responsiveness in atopic and nonatopic subjects.
Miadonna A; Milazzo N; Lorini M; Sala A; Tedeschi A
J Allergy Clin Immunol; 1996 Apr; 97(4):947-54. PubMed ID: 8655890
[TBL] [Abstract][Full Text] [Related]
3. Nasal neutrophilia and eosinophilia induced by challenge with platelet activating factor.
Tedeschi A; Palumbo G; Milazzo N; Miadonna A
J Allergy Clin Immunol; 1994 Feb; 93(2):526-33. PubMed ID: 8120279
[TBL] [Abstract][Full Text] [Related]
4. Nasal response to a single antigen challenge in patients with allergic rhinitis - inflammatory cell recruitment persists up to 48 hours.
Miadonna A; Milazzo N; Gibelli S; Salmaso C; Lorini M; Tedeschi A
Clin Exp Allergy; 1999 Jul; 29(7):941-9. PubMed ID: 10383595
[TBL] [Abstract][Full Text] [Related]
5. Eosinophil and eosinophil cationic protein in allergic rhinitis.
Beppu T; Ohta N; Gon S; Sakata K; Inamura K; Fukase S; Kimura Y; Koike Y
Acta Otolaryngol Suppl; 1994; 511():221-3. PubMed ID: 8203234
[TBL] [Abstract][Full Text] [Related]
6. The effect of platelet-activating factor on the responsiveness of the human nasal airway.
Austin CE; Foreman JC
Br J Pharmacol; 1993 Sep; 110(1):113-8. PubMed ID: 8220870
[TBL] [Abstract][Full Text] [Related]
7. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
[TBL] [Abstract][Full Text] [Related]
8. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine.
Shin MH; Averill FJ; Hubbard WC; Chilton FH; Baroody FM; Liu MC; Naclerio RM
Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):660-6. PubMed ID: 8118633
[TBL] [Abstract][Full Text] [Related]
9. Effect of slow-release theophylline on nasal antigen challenge in subjects with allergic rhinitis.
Aubier M; Neukirch C; Maachi M; Boucara D; Engelstätter R; Steinijans V; Samoyeau R; Dehoux M
Eur Respir J; 1998 May; 11(5):1105-10. PubMed ID: 9648963
[TBL] [Abstract][Full Text] [Related]
10. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure.
Wang D; Clement P; Smitz J; De Waele M; Derde MP
Int Arch Allergy Immunol; 1995 Mar; 106(3):278-85. PubMed ID: 7888790
[TBL] [Abstract][Full Text] [Related]
11. Study of the effects of paf-acether on human nasal airways.
Leggieri E; Tedeschi A; Lorini M; Bianco A; Miadonna A
Allergy; 1991 Aug; 46(6):466-71. PubMed ID: 1720286
[TBL] [Abstract][Full Text] [Related]
12. Evidence of PAF-acether metabolic pathway activation in antigen challenge of upper respiratory airways.
Miadonna A; Tedeschi A; Arnoux B; Sala A; Zanussi C; Benveniste J
Am Rev Respir Dis; 1989 Jul; 140(1):142-7. PubMed ID: 2546468
[TBL] [Abstract][Full Text] [Related]
13. Alpha2-macroglobulin and eosinophil cationic protein in the allergic airway mucosa in seasonal allergic rhinitis.
Meyer P; Persson CG; Andersson M; Wollmer P; Linden M; Svensson C; Greiff L
Eur Respir J; 1999 Mar; 13(3):633-7. PubMed ID: 10232439
[TBL] [Abstract][Full Text] [Related]
14. Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways.
Erjefält JS; Greiff L; Andersson M; Matsson E; Petersen H; Linden M; Ansari T; Jeffery PK; Persson CG
Am J Respir Crit Care Med; 1999 Jul; 160(1):304-12. PubMed ID: 10390416
[TBL] [Abstract][Full Text] [Related]
15. Steroid-sensitive indices of airway inflammation in children with seasonal allergic rhinitis.
Meyer P; Andersson M; Persson CG; Greiff L
Pediatr Allergy Immunol; 2003 Feb; 14(1):60-5. PubMed ID: 12603713
[TBL] [Abstract][Full Text] [Related]
16. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
Takafuji S; Tadokoro K; Ito K; Nakagawa T
Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serum.
Rasp G; Thomas PA; Bujía J
Clin Exp Allergy; 1994 Dec; 24(12):1151-6. PubMed ID: 7889429
[TBL] [Abstract][Full Text] [Related]
18. Monitoring nasal allergic inflammation by measuring the concentration of eosinophil cationic protein and eosinophils in nasal secretions.
Wang D; Clement P; Smitz J; de Waele M; Derde MP
Allergy; 1995 Feb; 50(2):147-51. PubMed ID: 7604937
[TBL] [Abstract][Full Text] [Related]
19. Allergen-induced inflammation in the nose: a comparison of acute and repeated low-dose allergen exposure.
Roquat A; Ihre E; van Hage-Hamsten M; Halldén G; Zetterström O
Allergy; 1996 Jan; 51(1):42-8. PubMed ID: 8721527
[TBL] [Abstract][Full Text] [Related]
20. Quantification of eosinophil cationic protein and eosinophils in nasal secretions of allergen-induced nasal inflammation.
Wang DY; Clement P; Smitz J; De Waele M; Derde MP
Allergol Immunopathol (Madr); 1994; 22(4):179-83. PubMed ID: 7976971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
